Christopher Thomas Scott
Publication Details
-
Gilead's deal of a lifetime.
Nat Biotechnol. 2009; (5): 423Gilead Sciences' ascent to the upper echelon of biotech centered around one very savvy acquisition that launched an HIV franchise.
